Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2

Journal of Pharmacology and Experimental Therapeutics

Volumn 265, Issue 1, 1993, Pages 401-407

  Tassaneeyakul, W ^a   Birkett, D J ^a   Veronese, M E ^a   McManus, M E ^a   Tukey, R H ^a   Quattrochi, L C ^a   Gelboin, H V ^a   Miners, J O ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; 7 ETHOXYCOUMARIN; ALPHA NAPHTHOFLAVONE; BERGAPTEN; CAFFEINE; COMPLEMENTARY DNA; CYTOCHROME P450 ISOENZYME; EDRECOLOMAB; ELLIPTICINE; ETHOXYRESORUFIN; METHOXSALEN; NIFEDIPINE; PARAXANTHINE; PHENACETIN; PROPRANOLOL; THEOBROMINE; THEOPHYLLINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG SELECTIVITY; ENZYME INHIBITION; ENZYME KINETICS; ENZYME SPECIFICITY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; LIVER METABOLISM; LIVER MICROSOME; METABOLIC INHIBITION; PRIORITY JOURNAL;

ALKYLATION; ANTIBODIES, MONOCLONAL; CYTOCHROME P-450 ENZYME SYSTEM; HUMAN; ISOENZYMES; MICROSOMES, LIVER; MOLECULAR PROBES; PHENACETIN; SUBSTRATE SPECIFICITY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; XENOBIOTICS;

EID: 0027364928     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)